Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
Cilta-Cel Bests Standard Care in Early Lenalidomide-Refractory MM
Katie Robinson
Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development
Anna Azvolinsky, PhD
Second-Line Axi-Cel Delivers OS Benefit for R/R LBCL
Leah Lawrence
Isa-Kd Prolongs PFS to Almost Three Years in Early Relapsed MM Follow-up Study
Katie Robinson
Ruxolitinib Demonstrates Superior Benefits in PV Resistant or Intolerant to Hydroxycarbamide
Linda Kossoff
First-Line Subcutaneous Rituximab May Increase PFS in Low Tumor Burden FL
Katie Robinson
Bleeding Symptoms in Patients With Ehlers-Danlos Syndrome Range From Mild to Life-Threatening
Linda Kossoff
JAK2-Unmutated Erythrocytosis From Gliflozins Appears Benign
Thomas R. Collins
Rituximab Maintenance Effective for Autoimmune Cytopenias
Thomas R. Collins
Risk Score Helps Identify Patients With CH at High Risk of Myeloid Malignancy
Anna Azvolinsky, PhD
Site of Cancer Could Predict VTE Recurrence After Anticoagulation Cessation
Leah Lawrence
BM MRD Status at One Month Post-CAR-T May Predict PFS in Patients with MM
Khylia Marshall
Bortezomib-Based Maintenance May Not Improve Outcomes for Patients With High-Risk MM Undergoing AHCT
Katie Robinson
Study Offers More Data on Efficacy for Venetoclax in R/R AL Amyloidosis
Thomas R. Collins
Elevated Blood Flow Velocity Associated With Risk of Cognitive Deficits in Pediatric SCD
Thomas R. Collins
Menin Inhibitor Revumenib Produces Strong Responses in R/R KMT2A-Rearranged Leukemia
Thomas R. Collins
Combined Pelabresib, Ruxolitinib Improved Splenomegaly in JAK Inhibitor Treatment-Naïve MF
Katie Robinson
Preexisting T-Cell Landscape May Determine Bispecific TCE Therapy Response in MM
Katie Robinson
COVID-19 Bivalent Boosters Associated With Few Definitive Hematologic AEs
Brandon May
2022 ELN Genetic-Risk Stratification Does Not Predict Outcomes Better Than 2017 Stratification for Adults With AML
Khylia Marshall

Advertisement

Connect with us:

CURRENT ISSUE
September 2023

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2023 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement